Apogee Therapeutics, Inc.
APGENASDAQHealthcare● Active
$83.01
$-3.91(-4.50%)
Market Cap$5.1B
P/E Ratio—
52W High$95.315
52W Low$34.34
Apogee Therapeutics, Inc.（APGE）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · APGE · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — | — | — |
| Operating Expenses | ||||
| R&D Expenses | $0.21B | $0.17B | $0.07B | $0.03B |
| G&A Expenses | $0.07B | $0.05B | $0.02B | $0.00B |
| Total Operating Expenses | $0.28B | $0.22B | $0.09B | $0.03B |
| Operating Income | ($0.29B) | ($0.22B) | ($0.09B) | ($0.03B) |
| Operating Margin %(computed) | — | — | — | — |
| Interest Income | $0.03B | $0.03B | $0.01B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.01B |
| Income Before Tax | ($0.26B) | ($0.18B) | ($0.08B) | ($0.04B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.26B) | ($0.18B) | ($0.08B) | ($0.04B) |
| Net Margin %(computed) | — | — | — | — |
| Per Share & EBITDA | ||||
| EPS (Basic) | $-4.22 | $-3.30 | $-1.66 | $-0.79 |
| Wtd Avg Shares | 0.06B | 0.06B | 0.05B | 0.05B |
| EBITDA | ($0.28B) | ($0.22B) | ($0.07B) | ($0.04B) |
| EBITDA Margin %(computed) | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Apogee Therapeutics, Inc.
关于Apogee Therapeutics, Inc.（APGE）损益表
Apogee Therapeutics, Inc.（APGE）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，APGE实现营收$0.00B，毛利润($0.00B)（毛利率—），净利润($0.26B)（净利率—）。
常见问题
APGE · 4 问Apogee Therapeutics, Inc.（APGE）2025财年营收为$0.00B，同比down—%。
APGE revenueAPGE salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08